• Home
  • CONVALIFE PHARMACEUTICALS CO.,LTD
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 4K91
Book a meeting

CONVALIFE PHARMACEUTICALS CO.,LTD

About CONVALIFE PHARMACEUTICALS CO.,LTD

Convalife Pharmaceuticals is a commercial-stage biopharmaceutical company driven by efficient innovation, with a vision to develop breakthrough therapies. We focus on innovative medicines for cancer treatment, while also advancing drug R&D and commercialization targeting viral and aging-related diseases. Adopting a dual strategy balancing commercialization and clinical development, we have built a diversified product portfolio including one marketed product, two core assets, two key candidates and another 12 pipeline drug candidates.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 4K91
  • Country/Region:
    China
  • On CPHI since:
    2026
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Contact info
Show contact info Hide contact info

Products from CONVALIFE PHARMACEUTICALS CO.,LTD (1)

  • Hannaijia (Neratinib Maleate Tablets)

    Product Hannaijia (Neratinib Maleate Tablets)

    Hannaijia, the brand name of Neratinib Maleate Tablets, is an oral irreversible pan-human epidermal growth factor receptor (pan-HER) tyrosine kinase inhibitor. It is indicated for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer following adjuvant trastuzu...